A clinical study to assess the effect of darvyadi lauha and dhatri lauha in pregnant female having anemia

A clinical study to assess the comparative effect of darvyadi lauha and dhatri lauha in garbhini pandu -An open labelled randomized clinical trial - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075456

Enrollment

Registered

2024-10-17

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D508- Other iron deficiency anemias

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Pregnant Females Of Age Group Of 18-35 Years Of Life 2)Pregnant Females In 2nd Trimester Of Pregnancy(14 wks to 28 wks) 3)Patients Fulfilling Diagnostic Criteria 4)Patients Willing To Participate In The Trial

Exclusion criteria

Exclusion criteria: 1)Patients Suffering From Pregnancy Related Complication Like PIH Hyperemesis gravidarum Preeclampsia etc 2)1st and 3rd Trimester Of Pregnancy 3)Patients Of High Risk Group Of Pregnancy 4)Patients Having Hb% Count Less Than 8gm% And More Than 10gm% 5)Patients Having Haemoglobinopathies (Such As Haemophilia Beta Thalassemia etc 6)Pregnancy Associated With Medical Disorders And Obstetrics Complications

Design outcomes

Primary

Measure	Time frame
Relief In Sign And Symptoms Of Garbhini Pandu(30% - 40%) Timepoint: 1st follow up -15 days after completion of treatment. 2nd follow up- 15 days after 1st follow up.	—

Secondary

Measure	Time frame
: Increase in Hb level of patient(2-3gm% approx.). Timepoint: 1st follow up -15 days after completion of treatment. 2nd follow up- 15 days	—

Countries

India

Contacts

Public ContactArti Rajeshwar Domatwar

All India Institute Of Ayurveda

kd44ayu@yahoo.co.in8920900968

Outcome results